Evidence-Based Minireview: Does achieving MRD negativity after initial therapy improve prognosis for high-risk myeloma patients? Sidana, S., Manasanch, E. AMER SOC HEMATOLOGY. 2019: 142–47

View details for Web of Science ID 000538564000020